These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15251228)

  • 1. The quest for new cysteinyl-leukotriene and lipoxin receptors: recent clues.
    Norel X; Brink C
    Pharmacol Ther; 2004 Jul; 103(1):81-94. PubMed ID: 15251228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo.
    Chiang N; Serhan CN; Dahlén SE; Drazen JM; Hay DW; Rovati GE; Shimizu T; Yokomizo T; Brink C
    Pharmacol Rev; 2006 Sep; 58(3):463-87. PubMed ID: 16968948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International Union of Pharmacology XXXVII. Nomenclature for leukotriene and lipoxin receptors.
    Brink C; Dahlén SE; Drazen J; Evans JF; Hay DW; Nicosia S; Serhan CN; Shimizu T; Yokomizo T
    Pharmacol Rev; 2003 Mar; 55(1):195-227. PubMed ID: 12615958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cysteinyl leukotrienes and their receptors: molecular and functional characteristics.
    Singh RK; Gupta S; Dastidar S; Ray A
    Pharmacology; 2010; 85(6):336-49. PubMed ID: 20516735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional studies of leukotriene receptors in vascular tissues.
    Walch L; Norel X; Gascard JP; Brink C
    Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 2):S107-11. PubMed ID: 10673237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Leukotrienes: potential therapeutic targets in cardiovascular diseases].
    Bäck M
    Bull Acad Natl Med; 2006 Oct; 190(7):1511-8; discussion 1518-21. PubMed ID: 17450683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-inflammatory circuitry: lipoxin, aspirin-triggered lipoxins and their receptor ALX.
    Chiang N; Arita M; Serhan CN
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):163-77. PubMed ID: 16125378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukotrienes: lipid bioeffectors of inflammatory reactions.
    Sala A; Zarini S; Bolla M
    Biochemistry (Mosc); 1998 Jan; 63(1):84-92. PubMed ID: 9526099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of leukotrienes in the pathophysiology of inflammatory disorders: is there a case for revisiting leukotrienes as therapeutic targets?
    Sharma JN; Mohammed LA
    Inflammopharmacology; 2006 Mar; 14(1-2):10-6. PubMed ID: 16835707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophils, endothelial cells, and cysteinyl leukotrienes: a new approach to neutrophil-dependent inflammation?
    Sala A; Folco G
    Biochem Biophys Res Commun; 2001 May; 283(5):1003-6. PubMed ID: 11355871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional characteristics of cysteinyl-leukotriene receptor subtypes.
    Bäck M
    Life Sci; 2002 Jun; 71(6):611-22. PubMed ID: 12072150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukotrienes and atherosclerosis: new roles for old mediators.
    Jala VR; Haribabu B
    Trends Immunol; 2004 Jun; 25(6):315-22. PubMed ID: 15145321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoids co-interact with lipoxin A4 via lipoxin A4 receptor (ALX) up-regulation.
    Hashimoto A; Murakami Y; Kitasato H; Hayashi I; Endo H
    Biomed Pharmacother; 2007 Jan; 61(1):81-5. PubMed ID: 17184966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cysteinyl-leukotriene 1 receptor antagonist attenuates bleomycin-induced pulmonary fibrosis in mice.
    Izumo T; Kondo M; Nagai A
    Life Sci; 2007 Apr; 80(20):1882-6. PubMed ID: 17397875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapy of diseases mediated by 5-lipoxygenase pathway eicosanoids.
    Rubin P; Mollison KW
    Prostaglandins Other Lipid Mediat; 2007 May; 83(3):188-97. PubMed ID: 17481554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial cysteinyl leukotriene 2 receptor expression and myocardial ischemia/reperfusion injury.
    Moos MP; Funk CD
    Trends Cardiovasc Med; 2008 Oct; 18(7):268-73. PubMed ID: 19232956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A twist in anti-inflammation: annexin 1 acts via the lipoxin A4 receptor.
    Gavins FN; Sawmynaden P; Chatterjee BE; Perretti M
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):211-9. PubMed ID: 15982865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of cysteinyl leukotrienes in chronic inflammation and neoplasia of the intestine].
    Broom OJ; Nielsen OH
    Ugeskr Laeger; 2009 Jan; 171(4):243-6. PubMed ID: 19174041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additional functions for the cysteinyl leukotrienes recognized through studies of inflammatory processes in null strains.
    Austen KF
    Prostaglandins Other Lipid Mediat; 2007 May; 83(3):182-7. PubMed ID: 17481553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of a human membrane protein involved in cysteinyl leukotriene biosynthesis.
    Ago H; Kanaoka Y; Irikura D; Lam BK; Shimamura T; Austen KF; Miyano M
    Nature; 2007 Aug; 448(7153):609-12. PubMed ID: 17632548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.